Sutima Luangdilok

5PUBLICATIONS
45CO-AUTHORS
Solid tumoursGene and molecular therapyPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 07, 2026
The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

|May 04, 2026
Transdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer.

|Feb 28, 2023
Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac.

Passakorn Wanchaijiraboon, Panot Sainamthip, Nattaya Teeyapun

|Oct 27, 2022
Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment.

Passakorn Wanchaijiraboon, Nattaya Teeyapun, Nussara Pakvisal

|Oct 27, 2022
Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine.

Sutima Luangdilok, Passakorn Wanchaijiraboon, Nussara Pakvisal

Pageof 1

Frequent Collaborators

3 joint publications

Nussara Pakvisal

3 joint publications

Yong Poovorawan

2 joint publications

Napa Parinyanitikul

1 joint publications

Phimchanok Sakunpongpitiporn